# Estados financieros de empresas de Salud

Salud: ingresos y beneficio neto del último período registrado de cada empresa que Open Ledger cubre en este sector, cada una reconstruida a partir de informes públicos como un libro contable Beancount balanceado que puedes abrir e inspeccionar.

## Libros contables de empresas

| Empresa                                                                                    | Período                                                                                                         | Ingresos        | Ingreso neto   | Margen neto | Último análisis                                                                                                                        |
| ------------------------------------------------------------------------------------------ | --------------------------------------------------------------------------------------------------------------- | --------------- | -------------- | ----------- | -------------------------------------------------------------------------------------------------------------------------------------- |
| [Danaher](https://beancount.io/es/open-ledger/danaher)                                     | [`FY2026Q3`](https://www.sec.gov/Archives/edgar/data/313616/000031361626000199/dhr-20260925.htm)                | 6554 M US$      | 1235 M US$     | 18,8 %      | [Análisis de Danaher](https://beancount.io/es/blog/2026/10/23/danaher-fy2026-q3-earnings-analysis)                                     |
| [Elevance Health](https://beancount.io/es/open-ledger/elevance-health)                     | [`FY2026Q3`](https://www.sec.gov/Archives/edgar/data/1156039/000115603926000071/elv-20260930.htm)               | 51,4 mil M US$  | 1365 M US$     | 2,7 %       | [Análisis de Elevance Health](https://beancount.io/es/blog/2026/10/22/elevance-health-fy2026-q3-earnings-analysis)                     |
| [Eli Lilly](https://beancount.io/es/open-ledger/eli-lilly)                                 | [`FY2026Q3`](https://www.sec.gov/Archives/edgar/data/59478/000005947826000108/lly-20260930.htm)                 | 24,4 mil M US$  | 6451 M US$     | 26,4 %      | [Análisis de Eli Lilly](https://beancount.io/es/blog/2026/11/08/eli-lilly-fy2026-q3-earnings-analysis)                                 |
| [Healthcare Services Group](https://beancount.io/es/open-ledger/healthcare-services-group) | [`FY2026Q3`](https://www.sec.gov/Archives/edgar/data/731012/000073101226000059/hcsg-20260930.htm)               | 479,6 M US$     | 24,9 M US$     | 5,2 %       | [Análisis de Healthcare Services Group](https://beancount.io/es/blog/2026/10/25/healthcare-services-group-fy2026-q3-earnings-analysis) |
| [Hims Hers](https://beancount.io/es/open-ledger/hims-hers)                                 | [`FY2026Q3`](https://www.sec.gov/Archives/edgar/data/1773751/000177375126000246/hims-20260930.htm)              | 890,4 M US$     | -33 M US$      | -3,7 %      | [Análisis de Hims Hers](https://beancount.io/es/blog/2026/11/09/hims-hers-q3-2026-earnings-analysis)                                   |
| [Intuitive Surgical](https://beancount.io/es/open-ledger/intuitive-surgical)               | [`FY2026Q3`](https://www.sec.gov/Archives/edgar/data/1035267/000103526726000067/isrg-20261020.htm)              | 3048,7 M US$    | 522,8 M US$    | 17,1 %      | [Análisis de Intuitive Surgical](https://beancount.io/es/blog/2026/10/21/intuitive-surgical-fy2026-q3-earnings-analysis)               |
| [Johnson Johnson](https://beancount.io/es/open-ledger/johnson-johnson)                     | [`FY2026Q3`](https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/jnj-20260927.htm)                | 25,4 mil M US$  | 210 M US$      | 0,8 %       | [Análisis de Johnson Johnson](https://beancount.io/es/blog/2026/10/22/johnson-johnson-fy2026-q3-earnings-analysis)                     |
| [Medpace](https://beancount.io/es/open-ledger/medpace)                                     | [`FY2026Q3`](https://www.sec.gov/Archives/edgar/data/1668397/000166839726000036/medp-20260930.htm)              | 716 M US$       | 137,5 M US$    | 19,2 %      | [Análisis de Medpace](https://beancount.io/es/blog/2026/10/24/medpace-fy2026-q3-earnings-analysis)                                     |
| [Medtronic](https://beancount.io/es/open-ledger/medtronic)                                 | [`FY2027Q1`](https://www.sec.gov/Archives/edgar/data/1613103/000162828026059697/exhibit991-fy27q1earningsr.htm) | 9756 M US$      | 1470 M US$     | 15,1 %      | [Análisis de Medtronic](https://beancount.io/es/blog/2026/09/13/medtronic-fy2027-q1-earnings-analysis)                                 |
| [Molina Healthcare](https://beancount.io/es/open-ledger/molina-healthcare)                 | [`FY2026Q3`](https://www.sec.gov/Archives/edgar/data/1179929/000117992926000042/moh3q26_er.htm)                 | 11,1 mil M US$  | 38 M US$       | 0,3 %       | [Análisis de Molina Healthcare](https://beancount.io/es/blog/2026/10/22/molina-healthcare-fy2026-q3-earnings-analysis)                 |
| [Novo Nordisk](https://beancount.io/es/open-ledger/novo-nordisk)                           | [`FY2026Q3`](https://www.sec.gov/Archives/edgar/data/353278/000162828026069805/caq32026.htm)                    | 79,2 mil M DKK  | 16,7 mil M DKK | 21,1 %      | [Análisis de Novo Nordisk](https://beancount.io/es/blog/2026/11/08/novo-nordisk-q3-2026-earnings-analysis)                             |
| [Quest Diagnostics](https://beancount.io/es/open-ledger/quest-diagnostics)                 | [`FY2026Q3`](https://www.sec.gov/Archives/edgar/data/1022079/000102207926000097/dgx093020268-kex991.htm)        | 3097 M US$      | 312 M US$      | 10,1 %      | [Análisis de Quest Diagnostics](https://beancount.io/es/blog/2026/10/23/quest-diagnostics-fy2026-q3-earnings-analysis)                 |
| [Thermo Fisher](https://beancount.io/es/open-ledger/thermo-fisher)                         | [`FY2026Q3`](https://www.sec.gov/Archives/edgar/data/97745/000009774526000173/q32026earnings8kex99_1.htm)       | 12,1 mil M US$  | 1727 M US$     | 14,2 %      | [Análisis de Thermo Fisher](https://beancount.io/es/blog/2026/10/21/thermo-fisher-fy2026-q3-earnings-analysis)                         |
| [Unitedhealth](https://beancount.io/es/open-ledger/unitedhealth)                           | [`FY2026Q3`](https://www.sec.gov/Archives/edgar/data/731766/000073176626000255/earningsrelease3q26unh.htm)      | 112,7 mil M US$ | 4110 M US$     | 3,6 %       | [Análisis de Unitedhealth](https://beancount.io/es/blog/2026/10/24/unitedhealth-fy2026-q3-earnings-analysis)                           |

## Otros sectores

- [IA y semiconductores](https://beancount.io/es/open-ledger/sector/ai-and-semiconductors)
- [Nube y software](https://beancount.io/es/open-ledger/sector/cloud-and-software)
- [Consumo y retail](https://beancount.io/es/open-ledger/sector/consumer-and-retail)
- [Comercio electrónico](https://beancount.io/es/open-ledger/sector/ecommerce)
- [Finanzas y cripto](https://beancount.io/es/open-ledger/sector/financials-and-crypto)
- [Industria y energía](https://beancount.io/es/open-ledger/sector/industrials-and-energy)
- [Plataformas de internet](https://beancount.io/es/open-ledger/sector/internet-platforms)
- [Espacio y frontera](https://beancount.io/es/open-ledger/sector/space-and-frontier)
- [Viajes y transporte](https://beancount.io/es/open-ledger/sector/travel-and-transport)

**Aviso legal:** Open Ledger es una reconstrucción independiente de los estados financieros presentados públicamente por las empresas, con fines únicamente educativos e informativos; no constituye asesoramiento de inversión ni de ningún otro tipo. Beancount.io no está afiliado ni respaldado por ninguna de las empresas mostradas. Las cifras pueden contener errores o no reflejar las últimas presentaciones; las presentaciones regulatorias de cada empresa son la fuente autorizada.

## Where to look next

- [Sitemap](https://beancount.io/sitemap.xml) - all pages with hreflang alternates
- [LLMs index](https://beancount.io/llms.txt) - curated links for AI agents (also /llms-full.txt for full docs)
- [Documentation](https://beancount.io/docs) - every doc is also available as text/markdown via .md suffix or Accept negotiation
- [REST API reference](https://beancount.io/docs/api-reference) - interactive endpoints, schemas, authentication, and code samples
- [OpenAPI spec](https://beancount.io/openapi.json) - OpenAPI 3.1 spec for this website's public content endpoints; the product contract for ledger operations is at https://beancount.io/api-gateway/v1/openapi.json
- [GraphQL](https://beancount.io/graphql) - public, read-only content API over the blog and research logs (no credentials, no ledger data): 12 query fields over 23 types
- [MCP server](https://beancount.io/mcp) - Model Context Protocol at https://beancount.io/api-gateway/mcp
